Premas Life Sciences to handle Beckman’s liquid handling solutions in India
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers
This oxygen is being provided free-of-cost to several state governments across the country to bring immediate relief to over 1 lakh patients on a daily basis
On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios
Access to genomic testing, not therapy cost, is the biggest challenge
FY26 revenue rises to Rs. 4,359 crore as India’s leading CDMO strengthens global footprint with EU GMP certifications, UK MHRA approval and Europe supplies
Subscribe To Our Newsletter & Stay Updated